Product Includes | Product # | Quantity | Mol. Wt | Isotype/Source |
---|---|---|---|---|
Cyclin A2 (BF683) Mouse mAb | 4656 | 20 µl | 55 kDa | Mouse IgE |
Cyclin B1 Antibody | 4138 | 20 µl | 55 kDa | Rabbit  |
Cyclin D1 (92G2) Rabbit mAb | 2978 | 20 µl | 36 kDa | Rabbit IgG |
Cyclin D2 (D52F9) Rabbit mAb | 3741 | 20 µl | 31 kDa | Rabbit IgG |
Cyclin D3 (DCS22) Mouse mAb | 2936 | 20 µl | 31 kDa | Mouse IgG1 |
Cyclin E1 (HE12) Mouse mAb | 4129 | 20 µl | 48 kDa | Mouse IgG1 |
Cyclin E2 Antibody | 4132 | 20 µl | 48 kDa | Rabbit  |
Cyclin H Antibody | 2927 | 20 µl | 36 kDa | Rabbit  |
Anti-rabbit IgG, HRP-linked Antibody | 7074 | 100 µl | Goat  | |
Anti-mouse IgG, HRP-linked Antibody | 7076 | 100 µl | Horse  |
Please visit cellsignal.com for individual component applications, species cross-reactivity, dilutions, protocols, and additional product information.
Description
The Cyclin Antibody Sampler Kit provides an economical means of evaluating the presence of cyclin proteins in cells. The kit contains enough primary and secondary antibodies to perform two western blot experiments with each antibody.
Storage
Background
Control of the cell cycle is regulated by a multitude of cellular events and processes. The cyclin dependent kinases (CDK) regulate many of these pathways and constitute an active complex when associated with their cyclin partners. This activity is controlled primarily by phosphorylation, which determines subcellular localization of the CDK/cyclin complex (1,2). Some phosphorylation events control the function of cytoplasmic retention sequences while other events regulate nuclear localization and export sequence function (3,4). Cyclin and cyclin-dependent kinase inhibitor (CKI) levels are regulated by ubiquitination and degradation via the ubiquitin proteasome pathway (5). A variety of CKI proteins associate with these complexes and modulate access to regulatory domains on cyclins (6). Additional complexity is generated as the controlled protein levels of each cyclin oscillate with the stages of cell cycle. Increased expression of Cyclin D1 is associated with certain types of cancer (7,8) and may associate with TSC2 (tuberin) independent of its Cdk partner (9).
- Krempler, A. et al. (2005) Cell Mol Life Sci 62, 1379-87.
- Toyoshima, F. et al. (1998) EMBO J 17, 2728-35.
- Porter, L.A. and Donoghue, D.J. (2003) Prog Cell Cycle Res 5, 335-47.
- Benzeno, S. et al. (2006) Oncogene 25, 6291-303.
- Diehl, J.A. et al. (1997) Genes Dev 11, 957-72.
- Hirai, H. et al. (1995) Mol Cell Biol 15, 2672-81.
- Sherr, C.J. (1996) Science 274, 1672-7.
- Kim, J.K. and Diehl, J.A. (2009) J Cell Physiol 220, 292-6.
- Zacharek, S.J. et al. (2005) Cancer Res 65, 11354-60.
Background References
Trademarks and Patents
Limited Uses
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.